Gentex price target raised to $42 from $36 at B. Riley

B. Riley analyst Josh Nichols raised the firm’s price target on Gentex to $42 from $36 and keeps a Buy rating on the shares. The company reported Q4 results well above consensus estimates, the analyst tells investors in a research note. The company is seeing robust shipment growth and its margin expansion appears on target, the analyst tells investors in a research note.